JP2008501316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501316A5 JP2008501316A5 JP2007509640A JP2007509640A JP2008501316A5 JP 2008501316 A5 JP2008501316 A5 JP 2008501316A5 JP 2007509640 A JP2007509640 A JP 2007509640A JP 2007509640 A JP2007509640 A JP 2007509640A JP 2008501316 A5 JP2008501316 A5 JP 2008501316A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- composition
- isolated
- cytoprotective compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56404904P | 2004-04-20 | 2004-04-20 | |
| PCT/US2005/013646 WO2005112976A2 (en) | 2004-04-20 | 2005-04-20 | Probiotic compounds from lactobacillus gg and uses therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008501316A JP2008501316A (ja) | 2008-01-24 |
| JP2008501316A5 true JP2008501316A5 (enExample) | 2009-01-22 |
Family
ID=35428847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509640A Abandoned JP2008501316A (ja) | 2004-04-20 | 2005-04-20 | ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070123460A1 (enExample) |
| EP (1) | EP1745142A4 (enExample) |
| JP (1) | JP2008501316A (enExample) |
| CN (1) | CN1997748A (enExample) |
| CA (1) | CA2563702A1 (enExample) |
| WO (1) | WO2005112976A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| BRPI0510004A (pt) * | 2004-04-20 | 2007-09-18 | Univ Chicago | artigo de manufatura, métodos para administrar uma composição terapêutica a um epitélio de um indivìduo, para tratar uma condição mediada por micróbio de um epitélio de um indivìduo, para melhorar um sintoma de uma condição e para prevenir uma condição, e, uso de composto tipo peg pma |
| BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
| JP4938005B2 (ja) | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
| CA2673465A1 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal |
| CN101273737B (zh) * | 2007-03-28 | 2011-08-24 | 哈尔滨正方科技有限公司 | 一种在常温下保持高活菌数的发酵乳饮料的制备方法 |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| US8748381B2 (en) | 2009-04-28 | 2014-06-10 | Vanderbilt University | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| US9848760B2 (en) * | 2009-06-29 | 2017-12-26 | Gearbox, Llc | Devices for continual monitoring and introduction of gastrointestinal microbes |
| US20120087902A1 (en) * | 2009-07-20 | 2012-04-12 | Bracco S.P.A. | Therapeutic Use Of Probiotics |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP2295535A1 (en) * | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
| US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
| US20180161381A1 (en) * | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections |
| CN113925884B (zh) * | 2020-06-29 | 2024-05-14 | 创百股份有限公司 | 后生元提取物用于促进皮肤再生与抗老化的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413785A (en) * | 1993-01-27 | 1995-05-09 | New England Deaconess Hospital Corp. | Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo |
| AU2001260791B2 (en) * | 2000-05-25 | 2006-11-09 | Nederlandse Organisatie Voor Toegepastnatuurwetenschappelijk Onderzoek Tno | Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
| US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
-
2005
- 2005-04-20 CN CNA2005800195831A patent/CN1997748A/zh active Pending
- 2005-04-20 CA CA002563702A patent/CA2563702A1/en not_active Abandoned
- 2005-04-20 EP EP05779952A patent/EP1745142A4/en not_active Withdrawn
- 2005-04-20 WO PCT/US2005/013646 patent/WO2005112976A2/en not_active Ceased
- 2005-04-20 JP JP2007509640A patent/JP2008501316A/ja not_active Abandoned
-
2006
- 2006-10-16 US US11/581,719 patent/US20070123460A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501316A5 (enExample) | ||
| CN113736695B (zh) | 用于改善肠屏障功能的益生菌菌株及其应用 | |
| CN112999222B (zh) | 用于抑制单链rna病毒复制的治疗 | |
| ES2569391T3 (es) | Tritocualina para uso en el tratamiento de la fibrosis quística | |
| KR101302315B1 (ko) | 피라졸 유도체를 포함하는 호흡기 질환 예방 및 치료용 조성물 | |
| CN112402459B (zh) | 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用 | |
| JP2008538288A5 (enExample) | ||
| KR20190084056A (ko) | 인간 지방간염(nafld/nash)의 치료 및 역행을 위한 서방성 피르페니돈 함유 조성물의 약학적 용도 | |
| CN110099681A (zh) | 用于治疗口腔干燥症的组合物和方法 | |
| CN116113631B (zh) | 一类氰基化合物、其制备方法及用途 | |
| CN118497080A (zh) | 一种发酵粘液乳杆菌及其在制备缓解溃疡性结肠炎产品中的应用 | |
| WO2014053592A1 (en) | Esters of short chains fatty acids for use in the treatment of immunogenic disorders | |
| WO2020113579A1 (zh) | 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途 | |
| CN113546089B (zh) | 1-乙基-3，7-二甲基黄嘌呤在制备治疗肺炎药物中的应用 | |
| KR20220116468A (ko) | 펩티드 및 다당류의 새로운 접합체 | |
| WO2017155053A1 (ja) | 非アルコール性脂肪性肝疾患／非アルコール性脂肪性肝炎の治療剤 | |
| CN108578420B (zh) | 木犀草苷在制备防治脓毒血症药物中的应用 | |
| CN113101283B (zh) | 一种多苯环共轭分子在制备抗病毒药物中的用途及抗病毒药物 | |
| CN111700918B (zh) | 一种用于缓解酒精性肠道损伤的药品 | |
| AU2011208939B2 (en) | Compounds for use in the treatment of diseases | |
| JP4232866B2 (ja) | 細胞障害抑制剤 | |
| AU2018446089B2 (en) | Pharmaceutical use of anemoside B4 against acute gouty arthritis | |
| CN108641980B (zh) | 一种缓解内毒素感染的卵形拟杆菌及其应用 | |
| CN111635874A (zh) | 一株能够调控肠道阿克曼菌属相对丰度的脆弱拟杆菌 | |
| WO2014131360A1 (zh) | 普罗布考及其衍生物抗肿瘤转移的用途 |